89 Bio Inc (ETNB)

Mar 30, 2025

Swiss National Bank Grows Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World

Mar 30, 2025

Mar 29, 2025

Certain Options of 89bio, Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2025. - MarketScreener

Mar 29, 2025

Mar 29, 2025

Raymond James Financial Inc. Invests $2.95 Million in 89bio, Inc. (NASDAQ:ETNB) - Defense World

Mar 29, 2025

Mar 28, 2025

Are 89bio Inc (NASDAQ: ETNB) Analysts Predicting A Spike? - Stocks Register

Mar 28, 2025

Mar 24, 2025

Victory Capital Management Inc. Acquires 1,437 Shares of 89bio, Inc. (NASDAQ:ETNB) - Defense World

Mar 24, 2025

Mar 24, 2025

PNC Financial Services Group Inc. Increases Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World

Mar 24, 2025

Mar 24, 2025

89bio (NASDAQ:ETNB) Given Sell (D-) Rating at Weiss Ratings - Defense World

Mar 24, 2025

Mar 22, 2025

89bio, Inc. (NASDAQ:ETNB) Stock Holdings Lifted by Bank of New York Mellon Corp - Defense World

Mar 22, 2025

Mar 20, 2025

89bio, Inc. (NASDAQ:ETNB) Receives $27.56 Average Target Price from Analysts - Defense World

Mar 20, 2025

Mar 17, 2025

89bio, Inc. (NASDAQ:ETNB) Shares Sold by Steward Partners Investment Advisory LLC - Defense World

Mar 17, 2025

Mar 17, 2025

89bio (NASDAQ:ETNB) Research Coverage Started at The Goldman Sachs Group - Defense World

Mar 17, 2025

Mar 15, 2025

Citigroup Initiates Coverage on 89bio (NASDAQ:ETNB) - Defense World

Mar 15, 2025

Mar 14, 2025

Goldman Sachs starts 89bio stock with neutral, $11 target By Investing.com - Investing.com Australia

Mar 14, 2025

Mar 14, 2025

Goldman Sachs Initiates Coverage of 89bio (ETNB) with Neutral Recommendation - Nasdaq

Mar 14, 2025

Mar 14, 2025

Goldman Sachs Initiates Coverage on 89bio With Neutral Rating, $11 Price Target -March 14, 2025 at 07:21 am EDT - Marketscreener.com

Mar 14, 2025

Mar 14, 2025

Goldman Sachs starts 89bio stock with neutral, $11 target - Investing.com India

Mar 14, 2025

Mar 14, 2025

89bio initiated with a Neutral at Goldman Sachs - TipRanks

Mar 14, 2025

Mar 13, 2025

Commit To Buy 89bio At $7.50, Earn 25.1% Annualized Using Options - Nasdaq

Mar 13, 2025

Mar 13, 2025

Citigroup Initiates Coverage of 89bio (ETNB) with Buy Recommendation - Nasdaq

Mar 13, 2025

Mar 13, 2025

Citigroup Initiates 89bio Inc at Buy With $25 Price Target -March 13, 2025 at 07:13 am EDT - Marketscreener.com

Mar 13, 2025

Mar 13, 2025

89bio initiated with a Buy at Citi - TipRanks

Mar 13, 2025

Mar 11, 2025

Time nigh for I&I? Key data points ahead - BioWorld MedTech

Mar 11, 2025

Mar 11, 2025

89bio Inc (NASDAQ: ETNB) Is On The Fall - Stocks Register

Mar 11, 2025

Mar 08, 2025

89bio (NASDAQ:ETNB) Earns Sell (D-) Rating from Weiss Ratings - Defense World

Mar 08, 2025

Mar 07, 2025

Rhumbline Advisers Has $1.02 Million Stock Position in 89bio, Inc. (NASDAQ:ETNB) - Defense World

Mar 07, 2025

Mar 07, 2025

89bio FY2025 EPS Forecast Increased by Cantor Fitzgerald - Defense World

Mar 07, 2025

Mar 06, 2025

Boston Pharma Plays Catch Up To Akero, 89bio In MASH - Citeline News & Insights

Mar 06, 2025

Mar 06, 2025

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 06, 2025

Mar 06, 2025

New York State Common Retirement Fund Has $128,000 Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World

Mar 06, 2025

Mar 04, 2025

89bio to Participate in the Leerink Partners Global Healthcare Conference - The Manila Times

Mar 04, 2025

Mar 03, 2025

Can 89bio's Liver Disease Pipeline Impress Investors at Upcoming Leerink Conference? - StockTitan

Mar 03, 2025

Mar 03, 2025

Cantor maintains Overweight on 89bio stock, price target at $29 - Investing.com

Mar 03, 2025

Mar 03, 2025

Cantor maintains Overweight on 89bio stock, price target at $29 By Investing.com - Investing.com UK

Mar 03, 2025

Mar 03, 2025

H.C. Wainwright cuts 89bio stock price target to $21, maintains Buy By Investing.com - Investing.com South Africa

Mar 03, 2025

Mar 03, 2025

H.C. Wainwright cuts 89bio stock price target to $21, maintains Buy - Investing.com

Mar 03, 2025

Mar 03, 2025

89bio’s (ETNB) “Buy” Rating Reiterated at HC Wainwright - Defense World

Mar 03, 2025

Mar 01, 2025

89Bio Inc. Faces Financial Risks Amid Market Challenges for Approved Products - MSN

Mar 01, 2025

Mar 01, 2025

Decoding 89bio Inc (ETNB): A Strategic SWOT Insight - GuruFocus.com

Mar 01, 2025

Feb 28, 2025

89bio Inc. Advances Clinical Trials Amid Financial Losses - TipRanks

Feb 28, 2025

Feb 28, 2025

89bio (NASDAQ:ETNB) Stock Price Down 9.1%What's Next? - MarketBeat

Feb 28, 2025

Feb 28, 2025

89bio (NASDAQ:ETNB) Announces Earnings Results, Misses Estimates By $0.42 EPS - MarketBeat

Feb 28, 2025

Feb 28, 2025

Cantor Fitzgerald maintains 89bio stock with $29 target By Investing.com - Investing.com South Africa

Feb 28, 2025

Feb 28, 2025

Cantor Fitzgerald maintains 89bio stock with $29 target - Investing.com

Feb 28, 2025

Feb 28, 2025

89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates - The Globe and Mail

Feb 28, 2025

Feb 27, 2025

89bio, Inc. SEC 10-K Report - TradingView

Feb 27, 2025

Feb 27, 2025

89bio Secures $727.5M War Chest While Advancing Critical Phase 3 Trials — What's Next for ETNB? - StockTitan

Feb 27, 2025

Feb 27, 2025

89bio (ETNB) Projected to Post Earnings on Thursday - Defense World

Feb 27, 2025

Feb 23, 2025

89bio, Inc. (NASDAQ:ETNB) Receives $31.43 Consensus PT from Brokerages - Defense World

Feb 23, 2025

Feb 22, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for 89bio (NASDAQ:ETNB) - MarketBeat

Feb 22, 2025

Feb 20, 2025

Cell Sorting Market Size to Hit USD 601.89 Million by 2034 - BioSpace

Feb 20, 2025

Feb 20, 2025

Wall Street Analysts See a 171.42% Upside in 89BIO (ETNB): Can the Stock Really Move This High? - MSN

Feb 20, 2025

Feb 20, 2025

89bio, Inc. (NASDAQ:ETNB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Feb 20, 2025

Feb 20, 2025

Should You Buy 89BIO (ETNB) After Golden Cross? - Nasdaq

Feb 20, 2025